Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
Hosted on MSN
Why Florida Cannot Stop Its Exploding Python Problem
Released into the wild decades ago, Florida’s giant pythons have multiplied into an unstoppable force, devouring native wildlife and collapsing fragile ecosystems. David Letterman scorches Trump with ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...
After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...
Fashion trend forecasters should flag snake skin as the next big thing in the Sunshine State. The invasive Burmese python, which has been terrorizing the natural wildlife of the Florida Everglades for ...
The Florida government is ridding the Everglades of invasive pythons by allowing fashion brans to turn them into luxury accessories. Inverse Leathers Shopping will now save the planet. Florida ...
The governor held a press conference on Monday where he highlighted the success of a public-private partnership aimed at removing Pythons from Florida's Everglades.Gov. Ron DeSantis shared the success ...
FORTUNATELY, NOBODY WAS INJURED. CONTROLLING THE PYTHON POPULATION HERE IN FLORIDA, GOVERNOR DESANTIS SPOKE IN STUART TODAY ABOUT SOME NEW ACTIONS THE STATE PLANS TO TAKE TO CONTROL THE GROWTH OF ...
In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...
The trend of AI researchers developing new, small open source generative models that outperform far larger, proprietary peers continued this week with yet another staggering advancement. The goal is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback